China eyes anti-Covid-19 oral drug to boost image, reopen borders
In the face of new variants, China is racing against time to develop and produce antiviral oral drugs to boost its international image.
In the face of new variants, China is racing against time to develop and produce antiviral oral drugs to boost its international image.
The plan will leave more people in the country eligible for booster shots, with more details to be announced.
Travellers are expected to check on the travel advisories of their destination countries to determine their eligibility for Covid-19 saliva tests.
To facilitate quarantine-free border reopening, Hong Kong is also launching a health code system on Dec 10.
The information, however, will still be available on the MOH website.
Interior Secretary Eduardo Año said that herd immunity areas are those that have immunized 70 percent of its target population.
The newly-developed alloy can inactivate 99.75 percent of the SARS-CoV-2 virus within three hours and 99.99 percent within six hours.
The ministry is preparing to reopen the country to vaccinated tourists under the “Lao Travel Green Zone” programme.
Health Minister Khairy Jamaluddin said this was one of the preemptive measures taken in light of the new highly infectious Omicron variant.
Health Minister Khairy Jamaluddin said as of Dec 6, only 20% of Bangladesh's population and 24% of Laos' population had been fully vaccinated against Covid-19.